Key points are not available for this paper at this time.
Immune checkpoint inhibitors (ICIs) can elicit anticancer immune responses, but predictive biomarkers are needed. We measured programmed death ligand 1 (PD-L1) expression in organs and lymph nodes using
Miedema et al. (Sat,) studied this question.